SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-022763
Filing Date
2024-05-13
Accepted
2024-05-13 07:33:15
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q avtx-20240331.htm   iXBRL 10-Q 880482
2 EX-10.1 ex-101_almataxflameantixil.htm EX-10.1 311529
3 EX-10.2 ex-102_lillyandflamebiosci.htm EX-10.2 291758
4 EX-10.3 ex-103_lillyandflamelicens.htm EX-10.3 21541
5 EX-31.1 ex-3111q2024.htm EX-31.1 10535
6 EX-31.2 ex-3121q2024.htm EX-31.2 10321
7 EX-32.1 ex-3211q2024.htm EX-32.1 11099
13 GRAPHIC avtx-20240331_g1.jpg GRAPHIC 492886
14 GRAPHIC flamebiosignaturea.jpg GRAPHIC 11360
15 GRAPHIC lillysiganturea.jpg GRAPHIC 1750
  Complete submission text file 0001628280-24-022763.txt   7792221

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20240331.xsd EX-101.SCH 56662
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avtx-20240331_cal.xml EX-101.CAL 64249
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avtx-20240331_def.xml EX-101.DEF 343046
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20240331_lab.xml EX-101.LAB 591234
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20240331_pre.xml EX-101.PRE 451707
79 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20240331_htm.xml XML 673531
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37590 | Film No.: 24936887
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)